The influence of renal insufficiency on the prognosis of acute myocardial infarction patients with metabolic syndrome
10.3969/j.issn.1006-5725.2015.14.019
- VernacularTitle:肾功能不全对合并代谢综合征的急性心肌梗死患者预后的影响
- Author:
Yuan GAO
;
Liang GUO
;
Xueyuan LI
;
Haishan ZHANG
;
Dandan FAN
;
Guoxian QI
;
Yingxian SUN
- Publication Type:Journal Article
- Keywords:
Renal insufficiency;
Metabolic syndrome;
Angioplasty;
Acute myocardial infarction
- From:
The Journal of Practical Medicine
2015;31(14):2303-2306
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the influence of renal insufficiency (RI) on long-term major adverse cardiac events (MACE) of patients with acute myocardial infarction (AMI) plus metabolic syndrome (MetS) and received percutaneous coronary intervention (PCI). Methods This was a retrospective study. From February, 2011 to Octorber, 2013 , we consecutivly enrolled 223 AMI patients with MetS in the First Affiliated Hospital of China Medical University. There were 88 patients with RI in group A, and 135 patients as the control group (group B). Patients were followed up for major adverse cardiac events (MACE) for 1 year. Results Compared with group B, the incidence of 1-year MACE of patients in group A was increased (36.4% vs. 18.5%, P= 0.003). Result of Cox proportional hazard regression analysis showed that RI was a predictive factor for 1-year MACE (HR = 3.56,95%CI 1.004 ~ 4.170, P = 0.002). Conclusion The incidence of 1-year MACE for AMI patients with RI and MetS post-PCI was high. RI was a risk factor for poor prognosis of AMI patients with MetS.